RPG Life Sciences Reports Strong Q4 Results, Highlights Growth in Pharmaceuticals Sector
RPG Life Sciences has announced its financial results for the quarter ending December 2024, highlighting strong growth in the pharmaceuticals sector. Key metrics include a significant increase in Profit Before Tax, Profit After Tax, and net sales, alongside improved operating profit margins and earnings per share, indicating enhanced overall performance.
RPG Life Sciences has reported its financial results for the quarter ending December 2024, showcasing a notable performance in the pharmaceuticals and drugs sector. The company has experienced a positive shift in its evaluation, with its score reflecting a significant adjustment over the past three months.The financial highlights indicate a robust growth trajectory. Profit Before Tax less Other Income (PBT) reached Rs 43.58 crore, marking a substantial increase compared to the average of the previous four quarters. Similarly, Profit After Tax (PAT) stood at Rs 34.93 crore, demonstrating a remarkable rise over the same period. Net sales also peaked at Rs 172.71 crore, the highest in the last five quarters, alongside an operating profit of Rs 49.16 crore, which is also a record for the company.
The operating profit margin has shown improvement, reaching 28.46%, reflecting enhanced efficiency. Additionally, earnings per share (EPS) hit Rs 21.12, indicating increased profitability for shareholders. However, it is worth noting that the non-operating income has also seen a rise, which may not be sustainable in the long term.
Overall, RPG Life Sciences has undergone a revision in its score, reflecting the positive trends in its financial performance.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
